Qian Song-Zan, Hong Wan-Dong, Pan Jing-Ye
Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wenzhou Key Laboratory of Critical Care and Artificial Intelligence, Wenzhou, China.
Front Med (Lausanne). 2020 Sep 4;7:552002. doi: 10.3389/fmed.2020.552002. eCollection 2020.
Information about severe cases of 2019 novel coronavirus disease (COVID-19) infection is scarce. The aim of this study was to report the clinical characteristics and outcomes of severe and critical patients with confirmed COVID-19 infection in Wenzhou city. In this single-centered, retrospective cohort study, we consecutively enrolled 37 RT-PCR confirmed positive severe or critical patients from January 28 to February 16, 2020 in a tertiary hospital. Outcomes were followed up until 28-day mortality. Fifteen severe and 22 critical adult patients with the COVID-19 infection were included. Twenty-six (68.4%) were men. Echocardiography data results suggest that normal or increased cardiac output and diastolic dysfunction are the most common manifestations. Compared with severe patients, critical patients were older, more likely to exhibit low platelet counts and high blood urea nitrogen, and were in hospital for longer. Most patients had organ dysfunction during hospitalization, including 11 (29.7%) with ARDS, 8 (21.6%) with acute kidney injury, 17 (45.9%) with acute cardiac injury, and 33 (89.2%) with acute liver dysfunction. Eighteen (48.6%) patients were treated with high-flow ventilation, 9 (13.8%) with non-invasive ventilation, 10 (15.4%) with invasive mechanical ventilation, 7 (18.9%) with prone position ventilation, 6 (16.2%) with extracorporeal membrane oxygenation (ECMO), and 3 (8.1%) with renal replacement therapy. Only 1 (2.7%) patient had died in the 28-day follow up in our study. All patients had bilateral infiltrates on their chest CT scan. Twenty-one (32.3%) patients presented ground glass opacity (GGO) with critical patients more localized in the periphery and the center. The mortality of critical patients with the COVID-19 infection is low in our study. Cardiac function was enhanced in the early stage and less likely to develop into acute cardiac injury, but most patients suffered with acute liver injury. The CT imaging presentations of COVID-19 in critical patients were more likely with consolidation and bilateral lung involvement.
关于2019新型冠状病毒病(COVID-19)感染重症病例的信息匮乏。本研究旨在报告温州市确诊COVID-19感染的重症和危重症患者的临床特征及转归。在这项单中心回顾性队列研究中,我们于2020年1月28日至2月16日在一家三级医院连续纳入了37例经逆转录聚合酶链反应(RT-PCR)确诊为阳性的重症或危重症患者。对其转归进行随访直至28天死亡率。纳入了15例COVID-19感染的重症成年患者和22例危重症成年患者。26例(68.4%)为男性。超声心动图数据结果表明,心输出量正常或增加以及舒张功能障碍是最常见的表现。与重症患者相比,危重症患者年龄更大,更易出现血小板计数低和血尿素氮高的情况,且住院时间更长。大多数患者在住院期间出现器官功能障碍,包括11例(29.7%)发生急性呼吸窘迫综合征(ARDS)、8例(21.6%)发生急性肾损伤、17例(45.9%)发生急性心脏损伤以及33例(89.2%)发生急性肝功能障碍。18例(48.6%)患者接受了高流量通气治疗,9例(13.8%)接受了无创通气治疗,10例(15.4%)接受了有创机械通气治疗,7例(18.9%)接受了俯卧位通气治疗,6例(16.2%)接受了体外膜肺氧合(ECMO)治疗,3例(8.1%)接受了肾脏替代治疗。在我们的研究中,28天随访期内仅有1例(2.7%)患者死亡。所有患者胸部CT扫描均显示双侧浸润影。21例(32.3%)患者出现磨玻璃影(GGO),危重症患者的磨玻璃影更局限于外周和中央部位。在我们的研究中,COVID-19感染危重症患者的死亡率较低。早期心脏功能增强,发展为急性心脏损伤的可能性较小,但大多数患者患有急性肝损伤。COVID-19危重症患者的CT影像表现更易出现实变和双侧肺受累。